Sex differences in incidence and outcome of chronic lymphocytic leukemia patients

References

• Adams K F, Jr, Sueta C A, Gheorghiade M, O'Connor C M, Swartz T A, Koch G G, et al. Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 1999; 99: 1816–1821
   PubMed Web of Science ®Google Scholar
• Culic V, Miric D, Jukic I. Acute myocardial infarction: differing preinfarction and clinical features according to infarct site and gender. Int J Cardiol 2003; 90: 189–196
   PubMed Web of Science ®Google Scholar
• Janne P A, Gurubhagavatula S, Yeap B Y, Lucca J, Ostler P, Skarin A T, et al. Outcome of patients with advanced non-small cell lung cancer treated with gefitinib on an expanded access study. Lung Cancer 2004; 44: 221–230
   PubMed Web of Science ®Google Scholar
• Park J, Park B B, Kim J Y, Lee S H, Kim H Y, Kim J H, et al. Gefitinib monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer. Clin Cancer Res 2004; 10: 4383–4388
   PubMed Web of Science ®Google Scholar
• McArdle C S, McMillan D C, Hole D J. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg 2003; 90: 711–715
   PubMed Web of Science ®Google Scholar
• Sugimachi K, Matsuoka H, Matsufuji H, Maekawa S, Kai H, Okudaira Y. Survival rates of women with carcinoma of the oesophagus exceed those of men. Surg Gynecol Obstet 1987; 164: 541–545
   PubMedGoogle Scholar
• Ohnishi T, Oishi Y, Goto H, Yanada S, Abe K. Gender as a prognostic factor in patients with renal carcinoma. BJU Int 2002; 90: 32–36
   Web of Science ®Google Scholar
• Rooser B, Attewell R, Berg N O, Rydholm A. Survival in soft tissue sarcoma. Prognostic variables identified by multivariate survival analysis. Acta Orthop Scand 1987; 58: 516–522
   PubMed Web of Science ®Google Scholar
• Cartwright R A, Gurney A K, Moorman A V. Sex ratios and risks of hematological malignancies. Br J Haematol 2002; 118: 1071–1077
   PubMed Web of Science ®Google Scholar
• Provencio M, Espana P, Millan I, Sanchez A C, de la Torre A, Bonilla F, et al. Prognostic factor in Hodgkin's disease. Leuk Lymphoma 2004; 45: 1133–1139
   PubMed Web of Science ®Google Scholar
• Bennett J M, Young M L, Andersen J W, Cassileth P A, Tallman M S, Paletta E, et al. Long-term survival in acute myeloid leukaemia: the Eastern Cooperative Oncology Group experience. Cancer 1997; 80(11)2205–2209
   PubMed Web of Science ®Google Scholar
• Chessells J M, Richards S M, Bailey C C, Lilleyman J S, Eden O B. Gender and treatment outcome in childhood lymphoblastic leukemia: a report from the MRC UKALL trials. Br J Haematol 1995; 89: 364–372
   PubMed Web of Science ®Google Scholar
• Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Relter A, et al. Gender aspects in chronic myeloid leukaemia: long-term results from randomized studies. Leukemia 2005; 19: 984–989
   PubMed Web of Science ®Google Scholar
• Mandelli F, De Rossi G, Mancini P, Alberti A, Cajozzo A, Grignani F, et al. Prognosis of chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. J Clin Oncol 1987; 5: 398–407
   PubMed Web of Science ®Google Scholar
• Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukemia: the importance of age, sex and response to treatment in survival. A report from the MRC CLL 1 trial. MRC Working Party on Leukemia in Adults. Br J Haematol 1989; 72: 141–149
   PubMed Web of Science ®Google Scholar
• Lee J S, Dixon D O, Kantarjian H M, Keating M J, Talpaz M. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 1987; 69: 929–936
   PubMed Web of Science ®Google Scholar
• Paolino W, Infelise V, Levis A, Marmont F, Vitolo U, Paolino F, et al. Adenosplenomegaly and prognosis in uncomplicated and complicated chronic lymphocytic leukemia. A study of 362 cases. Cancer 1984; 54: 339–346
   PubMed Web of Science ®Google Scholar
• Oscier D G, Gardiner A C, Mould S J, Glide S, Davis Z A, Ibbotson R E, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184
   PubMed Web of Science ®Google Scholar
• Morton L Y, Wang S S, Devesa S S, Hartge P, Weisenburg D D, Linet M S. Lymphoma incidence patterns by WHO subtype in the united States, 1992 – 2001. Blood 2006; 265–276
   PubMed Web of Science ®Google Scholar
• Diehl L F, Karnell L H, Menck H R. The National Cancer Data Base report on age, gender, treatment and outcomes of patients with chronic lymphocytic leukemia. Cancer 1999; 86: 2684–2692
   PubMed Web of Science ®Google Scholar
• Minot G B, Isaacs R. Lymphatic leukemia: age incidence, duration and benefit derived from irradiation. Boston Med Surg J 1924; 191: 1–9
   Google Scholar
• Reinhard E H, Neely C L, Samples D M. Radioactive phosphorus in the treatment of chronic leukemias: long-term results over a period of 15 years. Cancer 1959; 50: 942–958
   Google Scholar
• Call T G, Phyliky R L, Noel P, Habermann T M, Beard C M, O'Fallon W M, et al. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc 1994; 69: 323–328
   PubMed Web of Science ®Google Scholar
• Catovsky D, Halsey J, Richards S. Sex as a prognostic factor in CLL. An analysis from MRC trial. San Diego 22 – 24 March, 2002; IX IWCLL: 32a
   Google Scholar
• Ries L A, Kosary C L, Hanhkey B F. SEER cancer statistics review, 1975 – 2002: tables and graphs. National Cancer Institute, NIH publication, Bethesda, MD 2002, (Table XIII-9)
   Google Scholar
• Molica S, Mauro F R, Callea V, Gentile M, Giannarelli D, Lopez M, et al. A gender-based score system predicts the clinical outcome of patients with early B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2005; 46: 553–560
   PubMed Web of Science ®Google Scholar
• Hamblin T J, Orchard J A, Davies Z A, Ibbotson R E, Gardiner A C, Copplestone A, et al. In chronic lymphocytic leukemia females survive longer than males even in patients with unmutated immunoglobulin genes. Blood 2004; 104(1)9a
   Web of Science ®Google Scholar
• Catovsky D, Matutes E, Morilla A, Burford A, Brito-Babapulle V, Del Giudice, et al. Gender as a prognostic factor in CLL. Biological pointers to the improved outcome of women. Blood 2004; 104(1)274a
   Google Scholar
• Huang P, Feng L, Oldham E A, Keating M J, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390–395
   PubMed Web of Science ®Google Scholar
• Molica S. Quality of life in chronic lymphocytic leukaemia: a neglected issue. Leuk Lymphoma. 2005; 46: 1709–1714
   Google Scholar
• Stephen J M, Gramegna P, Laskin B, Botterman M F, Pashas C L. Chronic lymphocyticleukemia: Economic burden and quality of life. Am J Ther 2005; 12: 460–466
   PubMedGoogle Scholar
• Holzner B, Kemmler G, Kopp M, Kopp M, Sperner-Unterweger B, Kregnarm J, et al. Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over one year. Eur J Haematol 2004; 72: 381–389
   PubMed Web of Science ®Google Scholar
• Micheli A, Mariotto A, Giorgi R A, Gatta G, Muti P. The prognostic role of gender in survival of adult cancer patients. EUROCARE Working Group Eur J Cancer 1998; 34(14 Spec No)2271–2278
   PubMed Web of Science ®Google Scholar
• Shaw H M, Milton G W, Farago G, McCarthy W H. Endocrine influences on survival from malignant melanoma. Cancer 1978; 42: 669–677
   PubMed Web of Science ®Google Scholar
• Waldron I. Sex differences in illness incidence, prognosis and mortality: issue and evidence. Soc Sci Med 1983; 17: 1107–1123
   PubMed Web of Science ®Google Scholar